Patho-Seq
Patho-Seq is a new combination of sequencing protocol and Ripseq technologies adapted to meet FDA’s
specific requirements for approval for clinical use. Patho-Seq WILL NOT be available for sale until it has
received FDA marketing approval. If you wish to use Pathogenomix’s current technologies for research-only
purposes, please check out our current product Ripseq.
Read our latest press release
Pathogenomix granted FDA Breakthrough Device Designation
Santa Cruz, CA: January 19th 2022: The FDA has granted Patho-Seq a Breakthrough Device Designation due to its significant advantages compared to current FDA-approved methods
for the diagnosis of pathogenic bacteria in cases where infection may threaten life or long-term health.
Read more
Platform agnostic
Patho-Seq can analyze NGS direct-from-specimen sequencing files from any major hardware manufacturer. Using
our novel algorithms, the total time for one analysis is less than five minutes
- no matter if the sample is a pure sample or a complex poly microbial one.
Curated databases
Our Patho-Seq DB databases has the most up to date references, but without the clutter.
Databases are filtered and automatically curated to ensure an ID you can rely on.
Cloud SaaS solution
Patho-Seq is always online and always updated. All you need is an internet browser.
We push our new algorithms as well as new database references up to the cloud every
night for your benefit.
Patho-Seq NGS - It is FAST!
Using our novel algorithms Patho-Seq will process your targeted NGS sequence file locally,
and reduce the information needed to upload by a factor of 1000:1, while still retaining
resolution and specificity. This means no lengthy file upload, and no costly big
data file storage.
After upload, the cloud based Patho-Seq will analyze the uploaded reads against any
of our curated Patho-Seq DB databases - no matter the target.
All this in less than 5 minutes! Including reporting!
Patho-Seq DB - The best microbial database there is.
Pathogenomix's curated pathogen database Patho-Seq DB, extends and improves the effectiveness
of the public DNA sequence databases such as GenBank and others. While GenBank contains
large numbers of current references, it also has many uninformative or even erroneous
references that hinder accurate identification.
To ensure the best reference quality and accuracy, Patho-Seq DB enables users to
curate a more medically-relevant reference database. Users can annotate, reject
and approve references using personalized methods. This on top of the solid foundation
of advanced automatic filters and cross referencing makes Patho-Seq DB the database of
choice.
Curated databases are a prerequisite for rapid, accurate analysis of Next Generation
Sequencing (NGS) as well as Sanger data. This will ensure that the user can be confident
that the analysis results are complete and accurate.
Rapid Direct Sequencing Analysis of Clinical Samples using NGS or Sanger. Less than 5 minutes analysis time. No bioinformatics resources needed.
Long-read sequencing, long-read analysis, long-read preprocessor, nanopore, Direct Sequencing analysis, identification, mixed clinical samples, patient, dual loci, HLA, HIV, HPV, bacteria, bacterium, fungi, fungal, virus, Sanger, NGS, Ion, Torrent, Illumina, 16s gene, rpob gene, ITS, ITS2 gene, 16s metagenomics, metagenomic sequencing, amplicon, metagenomic sequencing, dna sequencing, fungal sequencing, isentio, bacterial, sequencing, metagenomic, metagenomics, nucleotide sequence, pathogenomix, pathoseq, pathongs, polymicrobial, sequencing, ripseq, rpob sequencing, second opinion, shotgun, metagenomics, targeted ngs, ngs sequencing, full metagenomic sequencing, amplicon